pCDCAR1 EGFRvIII h(γ), T(CAR-T-1-M315-G)
The vector of anti-EGFRvIII chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human EGFRvIII. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-EGFRvIII antibody linked to FcεRIγ signaling domains. And the vector product was designed for the treatment of glioma.
Targeting Cell Type
Discription of Signaling Cassetes
The high-affinity IgE receptor, also known as FcεRI, or Fc epsilon RI, is the high-affinity receptor for the Fc region of immunoglobulin E (IgE). FcεRI is a key molecule involved in allergic reactions. It is a tetramer composed of 1alpha, 1 beta, and 2 gamma chains. The gamma chains are also subunits of other Fc receptors. The scFv-based CARs engineered to contain a signaling domain from FcεRIγ have been shown to deliver a potent signal for T cell activation and function.
epidermal growth factor receptor
EGFR; epidermal growth factor receptor; ERBB; HER1; mENA; ERBB1; PIG61; NISBD2; Melanoma; CD28; Chimeric antigen receptor; T cell; Retrovirus; CARs; Lentivirus; chimeric T cell receptors; chimeric immunoreceptors; chimeric antigen receptors; scFv
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
||Anti-EGFR (Cetuximab) h(CD3ζ) CAR, pCDCAR1
||Anti-EGFR (R1) h(CD3ζ) CAR, Pcdcar1
||Anti-EGFRvIII (RAbDMvIII) h(ICOS-CD3ζ) CAR, pCDCAR1
||Anti-EGFRvIII (Y10) h(41BB-CD3ζ) CAR, pCDCAR1
||Anti-EGFR (R1) h(41BB-CD3ζ) CAR, Pcdcar1
||Lenti-EGFRvIII CAR (scFv-DAP12, MR1.1) Viral Particle
||Anti-EGFRvIII (Y10) h(CD28-CD3ζ) CAR, pCDCAR1
||Lenti-EGFRvIII CAR (scFv-CD28-OX40-CD3ζ, MR-1) Viral Particle
||Anti-EGFRvIII scFv h(CD4-CD3ζ) CART, pCDCAR1
||Anti-EGFR (Nimotuzumab) h(CD28-41BB-CD3ζ) CAR, pCDCAR1